Oct 31, 2022
Growing SAB Roster Includes 11   KOLs from Across the U.S. , Europe , and Israel Expansion of KOL Presence and Global Centers of Excellence Continues to Accelerate the Progression of the LIBERTY ® Robotic System to Meet Future Regulatory and Commercialization Milestones HINGHAM, Mass. , Oct.
Oct 25, 2022
HINGHAM, Mass. , Oct. 25, 2022 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) today announced that it has closed its previously announced registered direct offering with a single institutional investor for the purchase and sale of 1,022,495 shares of the Company’s common stock (which
Oct 21, 2022
HINGHAM, Mass. , Oct. 21, 2022 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) today announced that it has entered into a definitive agreement with a single institutional investor for the purchase and sale of 1,022,495 shares of the Company’s common stock (which includes pre-funded
Oct 18, 2022
HINGHAM, Mass. , Oct. 18, 2022 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), announced that it has submitted the anticipated follow-up pre-submission package for the LIBERTY ® Robotic System to ensure the Company remains fully aligned with the U.S.
Oct 13, 2022
HINGHAM, Mass. , Oct. 13, 2022 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) announced a significant development milestone as it completed the GLP animal study for the LIBERTY® Robotic System, the first disposable robotic system being developed for endovascular procedures.
Oct 11, 2022
Suspending Development of SCS and Evaluating Alternatives for SCS Assets HINGHAM, Mass. , Oct. 11, 2022 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) has announced that, following the recent acquisition of the endovascular assets of Nitiloop Ltd.
Oct 10, 2022
Complements Existing Allowance in the U.S. as Global Jurisdictions Recognize the Uniqueness of the Technology HINGHAM, Mass. , Oct. 10, 2022 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) is continuing to expand its global intellectual property portfolio for the LIBERTY ® Robotic System
Oct 07, 2022
Integration with the LIBERTY® Robotic System & One & Done™ Technology May Enable Future Acceleration of Robotic Adoption; Represents an Additional Growth Opportunity by Accessing the $500 Million Chronic Total Occlusion (CTO) Market 1 through the Expansion of Robotic Ecosystem for Endovascular
Oct 04, 2022
Award-Winning Interventional Radiologist in the NY Metro Area Adds Significant Depth and Experience HINGHAM, Mass. , Oct. 04, 2022 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), which continues to be committed to expanding its capabilities, today announced the newest appointment to its

Displaying 55 - 63 of 147

Search Investor Relations